carlyle group/the (CG:NASDAQ GS)

Executive Profile*

Background*

Mr. Robert A. Essner, Bob is a Senior Advisor and Operating Executive at The Carlyle Group LP. Mr. Essner is a Senior Advisor to the global healthcare group. At The Carlyle Group, Mr. Essner focuses on identifying and global investment opportunities in the healthcare sector. Mr. Essner worked for 32 years in the pharmaceutical industry and during that time served in many leadership roles. He has been the Chief Executive Officer of Fort Dodge Animal Health, Inc., since ... May 2001. Mr. Essner served as the Chairman, Chief Executive Officer and President of Wyeth K.K. He served as the President of Fort Dodge Animal Health, Inc., since May 2001. He served as the Chief Executive Officer of Wyeth Pharmaceuticals Inc., until January 2008. Mr. Essner served as Executive Chairman of Wyeth, LLC from January 1, 2003 to June 27, 2008 and its Chief Executive Officer since May 2001. He served as the President of Wyeth, LLC from July 2000 to April 2006 and Chief Operating Officer since July 2000 and Executive Vice President since September 1997. He served as the President of Wyeth-Ayerst Global Pharmaceuticals since March 1997 and the President of Wyeth-Ayerst Laboratories from 1993 to March 1997. Mr. Essner served as the President of Wyeth-Ayerst Laboratories, U.S. Pharmaceuticals Business from March 1997 to September 1997 and served as the President of Wyeth-Ayerst Laboratories Division from September 1997 to July 2000 and served as its Executive Vice President from July 2000 to May 2001 and also President and Chief Operating Officer from May 2001 to December 2002. He joined Wyeth in 1989 as a Senior Vice President of Sales and Marketing at Wyeth-Ayerst Laboratories. Mr. Essner joined Wyeth-Ayerst from Sandoz Pharmaceuticals Corporation, where he served as the Chief Operating Officer since 1988. He serves as Chairman of Pharmaceutical Research and Manufacturers of America. He serves as the Chairman of Wyeth Pharmaceuticals, Inc. He served as Non Executive Chairman of Wyeth since January 1, 2008 and its Director since 1997. He served as the Chairman of Fort Dodge Animal Health, Inc., since January 1, 2003. Mr. Essner served as the Chairman of the Children's Health Fund Corporate Council for 13 years and serves on their Board of Trustees. He serves as a Director of Met-Rx USA, Inc. and Massachusetts Massachusetts Mutual Life Insurance Company. He has been a Director of Amicus Therapeutics, Inc., since June 20, 2012. He has been Director of NBTY, Inc., since February 2011. He serves as is Director of Jaguar Holding Co I. He serves as a Director of Sandoz Pharmaceuticals AG. He serves as a Director and Trustee of Lincoln Center for the Performing Arts Inc. He serves as a Trustee of Pharmaceutical Product Development, Inc. He served as a Lead Director of Massachusetts Mutual Life Insurance Company. Mr. Essner serves as a Trustee of Penn Medicine (the entity governing the University of Pennsylvania School of Medicine and the University of Pennsylvania Health System). He also serves as a Member of the Business Roundtable and Business Council. He is a trustee of the Children's Health Fund and Mote Marine Laboratory, Inc. Mr. Essner is also an Executive-in-Residence and Adjunct Professor at Columbia Business School, where he teaches courses in healthcare management. Mr. Essner is an Executive-in-Residence and Adjunct Professor at Columbia Business School, where he teaches courses in Healthcare Management. Mr. Essner received a Master Degree from the University of Chicago and graduated with a Bachelors degree from Miami University, Oxford, Ohio.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
CG:US	$30.76 USD	+0.50

COMPETITOR COMPENSATION